The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2016

Filed:

Nov. 14, 2012
Applicant:

Steven J. Burden, New York, NY (US);

Inventor:

Steven J. Burden, New York, NY (US);

Assignee:

New York University, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61P 21/00 (2006.01); C07K 16/28 (2006.01); G01N 33/573 (2006.01); A61K 31/7088 (2006.01); A61K 38/00 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
G01N 33/573 (2013.01); A61K 31/7088 (2013.01); A61K 38/005 (2013.01); A61K 39/3955 (2013.01); A61K 39/39541 (2013.01); C07K 16/286 (2013.01); C07K 14/705 (2013.01); C07K 16/28 (2013.01); C07K 2317/33 (2013.01); C07K 2317/75 (2013.01); G01N 2500/04 (2013.01);
Abstract

Agents, compositions, and medicaments that pertain to modulating the activity of muscle specific kinase receptor (MuSK) and methods and uses thereof to modulate MuSK activity are encompassed herein. Also encompassed are screening assays to identify modulators of MuSK activity. Agents identified using the screening assays described herein are envisioned for use as therapeutics, alone or in compositions or in medicaments, to alleviate or delay motor dysfunction in subjects afflicted with a disorder associated with nerve terminal loss or fragmentation, such as amyotrophic lateral sclerosis, sarcopenia, or anti-MuSK myasthenia gravis.


Find Patent Forward Citations

Loading…